Welcome to LookChem.com Sign In|Join Free
  • or
cyclopropyl-(3-methoxy-2-methyl-benzyl)-amine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

790663-45-5

Post Buying Request

790663-45-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

790663-45-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 790663-45-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,9,0,6,6 and 3 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 790663-45:
(8*7)+(7*9)+(6*0)+(5*6)+(4*6)+(3*3)+(2*4)+(1*5)=195
195 % 10 = 5
So 790663-45-5 is a valid CAS Registry Number.

790663-45-5Relevant academic research and scientific papers

NOVEL COMPOUNDS AS INHIBITORS OF RENIN

-

Page/Page column 10, (2012/05/20)

The present invention relates to novel renin inhibitors of general formula (1), novel intermediates involved in their synthesis, their pharmaceutically acceptable salts and pharmaceutical compositions containing them. The present invention also relates to

NOVEL COMPOUNDS AS INHIBITORS OF RENIN

-

Page/Page column 21, (2010/11/05)

The present invention relates to novel renin inhibitors of general formula (1), novel intermediates involved in their synthesis, their pharmaceutically acceptable salts and pharmaceutical compositions containing them. The present invention also relates to

Design and preparation of potent, nonpeptidic, bioavailable renin inhibitors

Bezen?on, Olivier,Bur, Daniel,Weller, Thomas,Richard-Bildstein, Sylvia,Remeň, Lubo?,Sifferlen, Thierry,Corminboeuf, Olivier,Grisostomi, Corinna,Boss, Christoph,Prade, Lars,Delahaye, Stéphane,Treiber, Alexander,Strickner, Panja,Binkert, Christoph,Hess, Patrick,Steiner, Beat,Fischli, Walter

supporting information; experimental part, p. 3689 - 3702 (2010/04/02)

Starting from known piperidine renin inhibitors, a new series of 3,9-diazabicyclo[3.3.1]nonene derivatives was rationally designed and prepared. Optimization of the positions 3, 6, and 7 of the diazabicyclonene template led to potent renin inhibitors. The substituents attached at the positions 6 and 7 were essential for the binding affinity of these compounds for renin. The introduction of a substituent attached at the position 3 did not modify the binding affinity but allowed the modulation of the ADME properties. Our efforts led to the discovery of compound (+)-26g that inhibits renin with an IC 50 of 0.20 nM in buffer and 19 nM in plasma. The pharmacokinetics properties of this and other similar compounds are discussed. Compound (+)-26g is well absorbed in rats and efficacious at 10 mg/kg in vivo.

ORGANIC COMPOUNDS

-

Page/Page column 165, (2008/06/13)

3,4-substituted piperidine compounds, these compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (= disorder) that depends on activity of renin; the use of a compound of that cla

AZABICYCLONONENE DERIVATIVES AS RENIN INHIBITORS

-

Page/Page column 36, (2010/11/08)

The invention relates to novel bicyclononene derivatives, related compounds and use thereof as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the

AZABICYCLONONENE DERIVATIVES

-

Page 24, (2008/06/13)

The invention relates to novel 9-azabicyclo[3.3.1 ]nonene derivatives and related compounds and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the prep

DIAZABICYCLONONENE AND TETRAHYDROPYRIDINE DERIVATIVES AS RENIN INHIBITORS

-

Page 36, (2010/02/09)

The invention relates to novel 3,9-diazabicyclo[3.3.1]nonene derivatives, tetrahydropyridine derivatives, and related compounds and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspe

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 790663-45-5